Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (1743)	1/7/1999 9:53:00 PM
From: chirodoc	Read Replies (2) \| Respond to of 6039

pay attention? does that mean that you want me to start gettin' excited right now? or should i wait fer tomorrow? curtis gettin' curioser by the minute wonerin' what this old prospector found in that little crevass p.s. should i start the kettle? will we be expecting visitors? curtis

To: Prospector who wrote (1743)	1/8/1999 9:21:00 AM
From: Profiteer	Respond to of 6039

CTI's Subsidiary, Thermal Medical Imaging, Appoints New President January 8, 1999 09:00 AM OGDEN, Utah, Jan. 8 /PRNewswire/ -- Computerized Thermal Imaging, Inc. COII (CTI), a leader in the development of medical thermal imaging systems, announced today that the board of directors of its subsidiary, Thermal Medical Imaging, Inc., (TMI) appointed David A. Packer as the president of the Company. Packer replaces Kenneth Dodd who recently resigned his posts as president and board member for personal reasons. The board indicated that this change is effective immediately in order to ensure continuity in company operations. Packer remains president of CTI which owns an 80% interest in TMI. "CTI and TMI have worked closely on the clinical trials of our breast cancer technology and we believe this change will enable even closer coordination as we focus on completing the clinical trials," stated Packer. TMI uses CTI's technology to evaluate breast tissue suspected of being cancerous. In the on-going clinical trial, the results of the thermal images will be compared with participant's biopsy results to gauge the effectiveness of the new system. The intent of the new device is to be an adjunct to mammography and be used to more accurately detect breast cancer while reducing the number of benign biopsies. Preliminary testing of the system was very encouraging. Results indicate that the system may potentially decrease the number of benign biopsies performed by up to 38 percent. Computerized Thermal Imaging, Inc. develops and deploys thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 776-4700. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC

To: Prospector who wrote (1743)	1/8/1999 9:23:00 AM
From: Mr. K	Read Replies (1) \| Respond to of 6039

Is this the big surprise ? CTI's Subsidiary, Thermal Medical Imaging, Appoints New President OGDEN, Utah, Jan. 8 /PRNewswire/ -- Computerized Thermal Imaging, Inc. (OTC Bulletin Board: COII) (CTI), a leader in the development of medical thermal imaging systems, announced today that the board of directors of its subsidiary, Thermal Medical Imaging, Inc., (TMI) appointed David A. Packer as the president of the Company. Packer replaces Kenneth Dodd who recently resigned his posts as president and board member for personal reasons. The board indicated that this change is effective immediately in order to ensure continuity in company operations. Packer remains president of CTI which owns an 80% interest in TMI. "CTI and TMI have worked closely on the clinical trials of our breast cancer technology and we believe this change will enable even closer coordination as we focus on completing the clinical trials," stated Packer. TMI uses CTI's technology to evaluate breast tissue suspected of being cancerous. In the on-going clinical trial, the results of the thermal images will be compared with participant's biopsy results to gauge the effectiveness of the new system. The intent of the new device is to be an adjunct to mammography and be used to more accurately detect breast cancer while reducing the number of benign biopsies. Preliminary testing of the system was very encouraging. Results indicate that the system may potentially decrease the number of benign biopsies performed by up to 38 percent. Computerized Thermal Imaging, Inc. develops and deploys thermal imaging and associated technologies for use in the enhancement of medical screening, diagnosis and patient management. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 776-4700. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC. SOURCE Computerized Thermal Imaging, Inc. CO: Computerized Thermal Imaging, Inc.; Thermal Medical Imaging, Inc. ST: Utah IN: HEA CPR SU: PER 01/08/99 09:00 EST prnewswire.com